Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission

Journal of Affective Disorders

Volumn 142, Issue 1-3, 2012, Pages 77-81

  Zimmerman, Mark ^a   Martinez, Jennifer ^a   Attiullah, Naureen ^a   Friedman, Michael ^a   Toba, Cristina ^a   Boerescu, Daniela A ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Depression; Remission

Indexed keywords

ADULT; APPETITE DISORDER; ARTICLE; CLINICALLY USEFUL DEPRESSION OUTCOME SCALE; CONCENTRATION LOSS; DEATH PHANTASY; DEPRESSION; DISEASE SEVERITY; DSM-IV; FEMALE; GUILT; HAMILTON SCALE; HOPELESSNESS; HUMAN; HYPERSOMNIA; INCREASED APPETITE; INDECISIVENESS; INSOMNIA; LOSS OF INTEREST; LOW ENERGY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTPATIENT; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMOTOR RETARDATION; REMISSION; RESTLESSNESS; SUICIDAL IDEATION; SYMPTOM; WORTHLESSNESS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; RHODE ISLAND; SELF-ASSESSMENT; SYMPTOM ASSESSMENT;

EID: 84868159418     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.03.044     Document Type: Article

References (40)

1. J. Ballenger Clinical guidelines for establishing remission in patients with depression and anxiety Journal of Clinical Psychiatry 60 Suppl. 22 1999 29 34
2. H.J. Conradi, J. Ormel, and P. de Jonge Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study Psychological Medicine 2010 1 10
3. B. Cuffel, F. Azocar, M. Tomlin, S. Greenfield, A. Busch, and T. Croghan Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice Journal of Clinical Psychiatry 64 2003 397 402
4. I. Ferrier Treatment of major depression: is improvement enough? Journal of Clinical Psychiatry 60 Suppl. 6 1999 10 14
5. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0) 1995 Biometrics Research Department, New York State Psychiatric Institute New York
6. E. Frank, R. Prien, R. Jarrett, M. Keller, D. Kupfer, and P. Lavori Conceptualization and rationale for consensus definitions of terms in major depressive disorder Archives of General Psychiatry 48 1991 851 855
7. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry 23 1960 56 62
8. N. Iovieno, A. van Nieuwenhuizen, A. Clain, L. Baer, and A.A. Nierenberg Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse Depression and Anxiety 0 2010 1 8
9. L. Judd, M. Paulus, P. Schettler, H. Akiskal, J. Endicott, and A. Leon Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? The American Journal of Psychiatry 157 2000 1501 1504
10. M. Keller Past, present, and future directions for defining optimal treatment outcome in depression JAMA 289 2003 3152 3160
11. K. Kroenke, R. Spitzer, and J. Williams The PHQ-9. Validity of a brief depression severity measure Journal of General Internal Medicine 16 2001 606 613
12. B.T. Kurian, T.L. Greer, and M.H. Trivedi Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms Expert Review of Neurotherapeutics 9 2009 975 984
13. R. McIntyre, A. Fallu, and J. Konarski Measurable outcomes in psychiatric disorders: remission as a marker of wellness Clinical Therapeutics 28 2006 1882 1891
14. M. Menza, H. Marin, and R.S. Opper Residual symptoms in depression: can treatment be symptom-specific? Journal of Clinical Psychiatry 64 2003 516 523
15. I. Miller, G. Keitner, A. Schatzberg, D. Klein, M. Thase, and A. Rush The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine Journal of Clinical Psychiatry 59 1998 608 619
16. H.J. Moller Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment The World Journal of Biological Psychiatry 9 2008 102 114
17. A. Nierenberg, and E. Wright Evolution of remission as the new standard in treatment of depression Journal of Clinical Psychiatry 60 1999 7 11
18. A.A. Nierenberg, M.M. Husain, M.H. Trivedi, M. Fava, D. Warden, and S.R. Wisniewski Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STARD report Psychological Medicine 40 2010 41 50
19. A.A. Nierenberg, B.R. Keefe, V.C. Leslie, J.E. Alpert, J.A. Pava, and J.J. Worthington Residual symptoms in depressed patients who respond acutely to fluoxetine Journal of Clinical Psychiatry 60 1999 221 225
20. G.I. Papakostas, T. Petersen, J.W. Denninger, E. Tossani, J.A. Pava, and J.E. Alpert Psychosocial functioning during the treatment of major depressive disorder with fluoxetine Journal of Clinical Psychopharmacology 24 2004 507 511
21. E.S. Paykel, R. Ramana, Z. Cooper, H. Hayhurst, J. Kerr, and A. Barocka Residual symptoms after partial remission: an important outcome in depression Psychological Medicine 25 1995 1171 1180
22. L. Pintor, C. Gasto, V. Navarro, X. Torres, and L. Fananas Relapse of major depression after complete and partial remission during a 2-year follow-up Journal of Affective Disorders 73 2003 237 244
23. L.S. Radloff The CES-D scale: a self-report depression scale for research in the general population Applied Psychological Measurement 3 1977 385 401
24. I. Romera, V. Perez, J.M. Menchon, H. Delgado-Cohen, P. Polavieja, and I. Gilaberte Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study European Psychiatry 25 2010 58 65
25. A. Rush, M. Crismon, M. Toprac, M. Trivedi, W. Rago, and S. Shon Consensus guidelines in the treatment of major depressive disorder Journal of Clinical Psychiatry 59 1998 73 84
26. A. Rush, and M. Trivedi Treating depression to remission Psychiatric Annals 25 1995 704 709
27. A. Rush, M. Trivedi, H. Ibrahim, T. Carmody, B. Arnow, and D. Klein The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression Biological Psychiatry 54 2003 573 583
28. A.J. Rush, H.C. Kraemer, H.A. Sackeim, M. Fava, M.H. Trivedi, and E. Frank Report by the ACNP Task Force on response and remission in major depressive disorder Neuropsychopharmacology 31 2006 1841 1853
29. A.J. Rush, M.H. Trivedi, J.W. Stewart, A.A. Nierenberg, M. Fava, and B.T. Kurian Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study American Journal of Psychiatry 2011
30. S. Stahl Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy Journal of Clinical Psychiatry 60 1999 213 214
31. M. Thase Evaluating antidepressant therapies: remission as the optimal outcome Journal of Clinical Psychiatry 64 Suppl. 13 2003 18 25
32. M.E. Thase, A.D. Simons, J. McGeary, J.F. Cahalane, C. Hughes, and T. Harden Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment American Journal of Psychiatry 149 1992 1046 1052
33. M.H. Trivedi, P.K. Corey-Lisle, Z. Guo, R.D. Lennox, A. Pikalov, and E. Kim Remission, response without remission, and nonresponse in major depressive disorder: impact on functioning International Clinical Psychopharmacology 24 2009 133 138
34. L. Van London, R.P. Molenaar, J.G. Goekoop, A.H. Zwinderman, and H.G.M. Rooijmans Three- to 5-year prospective follow-up of outcome in major depression Psychological Medicine 28 1998 731 735
35. M. Zimmerman, I. Chelminski, J.B. McGlinchey, and M.A. Posternak A clinically useful depression outcome scale Comprehensive Psychiatry 49 2008 131 140
36. M. Zimmerman, W. Coryell, and B. Pfohl The treatment validity of DSM-III melancholic subtyping Psychiatry Research 16 1985 37 43
37. Zimmerman, M.; Martinez, J.; Attiullah, N.; Friedman, M.; Toba, C.; Boerescu, D.; et al.; 2012 Further evidence that the cutoff to define remission on the 17-item Hamilton Depression Rating Scale should be lowered. Depression and Anxiety 29, 160-166.
38. M. Zimmerman, M. Posternak, and I. Chelminski Is the cutoff to define remission on the Hamilton Rating Scale too high? Journal of Nervous and Mental Disease 193 2005 170 175
39. M. Zimmerman, M.A. Posternak, and I. Chelminski Heterogeneity among depressed outpatients considered to be in remission Comprehensive Psychiatry 48 2007 113 117
40. W.W.K. Zung A self-rating depression scale Archives of General Psychiatry 12 1965 63 70